Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.

Khurana RN, Appa SN, McCannel CA, Elman MJ, Wittenberg SE, Parks DJ, Ahmad S, Yeh S.

Ophthalmology. 2014 Jan;121(1):67-71. doi: 10.1016/j.ophtha.2013.06.033. Epub 2013 Jul 24.

PMID:
23890421
2.

Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.

Stelton CR, Townsend J, Peterson LT, Khurana RN, Yeh S.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug;46(7):756-9. doi: 10.3928/23258160-20150730-11.

PMID:
26247457
3.

[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].

Malclès A, Janin-Manificat H, Yhuel Y, Russo A, Agard E, El Chehab H, Ract Madoux G, Masse H, Burillon C, Dot C.

J Fr Ophtalmol. 2013 Apr;36(4):362-7. doi: 10.1016/j.jfo.2012.11.003. Epub 2013 Jan 12. French.

4.

Anterior segment migration of dexamethasone implant: risk factors, complications, and management.

Rahimy E, Khurana RN.

Curr Opin Ophthalmol. 2017 May;28(3):246-251. doi: 10.1097/ICU.0000000000000365. Review.

PMID:
28376511
5.

Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema.

Turaka K, Kwong HM Jr, De Souza S.

Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):196-7. doi: 10.3928/23258160-20130130-02. Epub 2013 Feb 12.

PMID:
23402344
6.

Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber.

Vela JI, Crespí J, Andreu D.

Int Ophthalmol. 2012 Dec;32(6):583-4. doi: 10.1007/s10792-012-9604-7. Epub 2012 Jul 5.

PMID:
22763812
7.

Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.

Stepanov A, Codenotti M, Ramoni A, Prati M, Jiraskova N, Rozsival P, Bandello F.

Eur J Ophthalmol. 2016 Apr 12;26(3):e52-4. doi: 10.5301/ejo.5000715.

PMID:
26615950
8.

Corneal toxicity after Ozurdex(®) migration into anterior chamber.

Bernal L, Estévez B.

Arch Soc Esp Oftalmol. 2016 Jun;91(6):292-4. doi: 10.1016/j.oftal.2016.01.008. Epub 2016 Feb 24. English, Spanish.

PMID:
26922138
9.

[Anterior chamber migration of a dexamethasone implant in a pseudophakic patient with a scleral-fixated posterior chamber intraocular lens].

Laplace O, Rodallec T, Akesbi J, Sandali O.

J Fr Ophtalmol. 2013 Apr;36(4):e59-61. doi: 10.1016/j.jfo.2012.06.022. Epub 2013 Feb 20. French.

10.

Management of anterior chamber dislocation of dexamethasone implant.

Kishore SA, Schaal S.

Ocul Immunol Inflamm. 2013;21(1):90-1. doi: 10.3109/09273948.2012.736589.

PMID:
23323589
11.

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.

Pacella F, Agostinelli E, Carlesimo SC, Nebbioso M, Secondi R, Forastiere M, Pacella E.

J Med Case Rep. 2016 Oct 13;10(1):282.

12.

Dislocation of dexamethasone intravitreous implant.

Voykov B, Bartz-Schmidt KU.

Arch Ophthalmol. 2012 Jun;130(6):706. doi: 10.1001/archophthalmol.2011.1611. No abstract available.

PMID:
22801827
13.

Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®).

Pardo-López D, Francés-Muñoz E, Gallego-Pinazo R, Díaz-Llopis M.

Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1703-4. doi: 10.1007/s00417-011-1802-x. Epub 2011 Aug 23. No abstract available.

PMID:
21861084
14.

[Dislocation in anterior chamber of dexamethasone intravitreal device].

Cousin M, Hoffart L, Baeteman C, Matonti F.

Can J Ophthalmol. 2013 Aug;48(4):e62-3. doi: 10.1016/j.jcjo.2013.01.008. French. No abstract available.

PMID:
23931482
15.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
16.

Steroid implant in anterior chamber of an aphakic vitrectomized eye.

Jonas JB, Schmidbauer M.

Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):385-6. doi: 10.1007/s00417-011-1839-x. Epub 2011 Oct 18. No abstract available.

PMID:
22005792
17.

The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).

Kang H, Lee MW, Byeon SH, Koh HJ, Lee SC, Kim M.

Graefes Arch Clin Exp Ophthalmol. 2017 Jun 10. doi: 10.1007/s00417-017-3705-y. [Epub ahead of print]

PMID:
28601910
18.

DEXAMETHASONE IMPLANT REMOVAL FROM ANTERIOR CHAMBER: SURGICAL TECHNIQUE.

Ruiz-Casas D, Gros-Otero J, Casado A.

Retin Cases Brief Rep. 2016 Fall;10(4):313-5. doi: 10.1097/ICB.0000000000000335.

PMID:
27124797
19.
20.

Removal of dislocated intraocular lenses using pars plana vitrectomy with placement of an open-loop, flexible anterior chamber lens.

Mittra RA, Connor TB, Han DP, Koenig SB, Mieler WF, Pulido JS.

Ophthalmology. 1998 Jun;105(6):1011-4.

PMID:
9627650

Supplemental Content

Support Center